Your browser doesn't support javascript.
loading
Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010-2015.
Rigobon, Alanna V; Kalia, Sumeet; Nichols, Jennica; Aliarzadeh, Babak; Greiver, Michelle; Moineddin, Rahim; Sullivan, Frank; Yu, Catherine.
Affiliation
  • Rigobon AV; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kalia S; University of Toronto Practice-Based Research Network, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Nichols J; Diabetes Canada, Toronto, Ontario, Canada.
  • Aliarzadeh B; Interdisciplinary Studies, University of British Columbia, Vancouver, British Columbia, Canada.
  • Greiver M; University of Toronto Practice-Based Research Network, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Moineddin R; University of Toronto Practice-Based Research Network, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Sullivan F; North York General Hospital, Toronto, Ontario, Canada.
  • Yu C; Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada.
Diabetes Care ; 42(1): 148-156, 2019 01.
Article in En | MEDLINE | ID: mdl-30389671

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Prescriptions / Angiotensin-Converting Enzyme Inhibitors / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 Type of study: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Diabetes Care Year: 2019 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Prescriptions / Angiotensin-Converting Enzyme Inhibitors / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 Type of study: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Diabetes Care Year: 2019 Document type: Article Affiliation country: Canada Country of publication: United States